The Lesch-Nyhan syndrome
暂无分享,去创建一个
[1] B. Bloem,et al. Delineation of the motor disorder of Lesch-Nyhan disease. , 2006, Brain : a journal of neurology.
[2] H. Kiefer,et al. Endogenes Kreatinin in Serum und Harn , 1963, Klinische Wochenschrift.
[3] W. Nyhan,et al. The recognition of Lesch-Nyhan syndrome as an inborn error of purine metabolism , 1997, Journal of Inherited Metabolic Disease.
[4] H. Polk,et al. Symposium introduction , 2004, Cell Biology and Toxicology.
[5] A. Buño,et al. The Spectrum of Hypoxanthine-Guanine Phosphoribosyltransferase (HPRT) Deficiency: Clinical Experience Based on 22 Patients from 18 Spanish Families , 2001, Medicine.
[6] H. Jinnah,et al. The spectrum of inherited mutations causing HPRT deficiency: 75 new cases and a review of 196 previously reported cases. , 2000, Mutation research.
[7] S. Takashima,et al. Neurotransmitter changes in the pathophysiology of Lesch–Nyhan syndrome , 2000, Brain and Development.
[8] W. Nyhan,et al. Dopamine function in Lesch-Nyhan disease. , 2000, Environmental Health Perspectives.
[9] H. Jinnah,et al. Lesch–Nyhan disease and the basal ganglia , 2000, Brain Research Reviews.
[10] M. Ernst,et al. Presynaptic dopaminergic deficits in Lesch-Nyhan disease. , 1996, The New England journal of medicine.
[11] W. Fujimoto,et al. Adenine Therapy for Lesch-Nyhan Syndrome , 1971, Pediatric Research.
[12] J. Trijbels,et al. THE INFLUENCE OF ADENINE ON THE CLINICAL FEATURES AND PURINE METABOLISM IN THE LESCH‐NYHAN SYNDROME , 1970, Acta paediatrica Scandinavica.
[13] H. Ghadimi,et al. THE SIGNIFICANCE OF THE DEFICIENCY STATE IN LESCH‐NYHAN DISEASE , 1970, Acta paediatrica Scandinavica.
[14] J. Wyngaarden,et al. Effects of allopurinol and oxipurinol on purine synthesis in cultured human cells. , 1970, The Journal of clinical investigation.
[15] S. Appel,et al. Synthesis de novo of purines in slices of rat brain and liver 1 , 1970, Journal of neurochemistry.
[16] S. Piomelli,et al. Elevated AMP pyrophosphorylase activity in congenital IMP pyrophosphorylase deficiencey (Lesch-Nyhan disease). , 1969, The Journal of laboratory and clinical medicine.
[17] W. Nyhan,et al. Quantitation of oxypurines and allopurinol metabolites in biological fluids by cation-exchange chromatography. , 1969, Analytical biochemistry.
[18] W. N. Kelley,et al. Hypoxanthine-guanine phosphoribosyltransferase deficiency in the Lesch-Nyhan syndrome and gout. , 1968, Federation proceedings.
[19] Rosenbloom Fm. Possible mechanism for increased purine biosynthesis de novo in Lesch-Nyhan syndrome. , 1968 .
[20] J. Seegmiller,et al. Biochemical bases of accelerated purine biosynthesis de novo in human fibroblasts lacking hypoxanthine-guanine phosphoribosyltransferase. , 1968, The Journal of biological chemistry.
[21] J. Dancis,et al. Diagnostic test for congenital hyperuricemia with central nervous system dysfunction. , 1968, The Journal of laboratory and clinical medicine.
[22] W. Nyhan. Clinical features of the Lesch-Nyhan syndrome. Introduction--clinical and genetic features. , 1968, Federation proceedings.
[23] J. F. Henderson. Kinetic properties of hypoxanthine-guanine and adenine phosphoribosyltransferases. , 1968, Federation proceedings.
[24] D. Ford,et al. H3 ACCUMULATION IN SPINAL CORD NEURONS FOLLOWING INTRAVENOUS INJECTION OF ADENINE‐H3 AS DETERMINED BY LIQUID SCINTILLATION COUNTING PROCEDURES ON DISSECTED NEURONS 1 , 1967, Acta neurologica Scandinavica.
[25] J. Seegmiller,et al. Enzyme Defect Associated with a Sex-Linked Human Neurological Disorder and Excessive Purine Synthesis , 1967, Science.
[26] H. Haury. [Determination of uric acid in serum]. , 1966, Medizinische Klinik.
[27] W. Nyhan,et al. A FAMILIAL DISORDER OF URIC ACID METABOLISM AND CENTRAL NERVOUS SYSTEM FUNCTION. , 1964, The American journal of medicine.
[28] N. Zöllner,et al. Eine einfache Modifikation der ensymatischen Harnsäurebestimmung , 1963 .
[29] N. Zöllner. Eine einfache Modifikation der enzymatischen Harnsäurebestimmung. Normalwerte in der deutschen Bevölkerung , 1963 .
[30] A. Bendich,et al. Adenine intoxication in relation to in vivo formation and deposition of 2,8-dioxyadenine in renal tubules. , 1952, The Journal of pharmacology and experimental therapeutics.